Despite FDA’s Request, Company Says It Won’t Pull Premature Birth Drug
The FDA says evidence doesn't show that Makena is effective for its approved use, but AMAG Pharmaceuticals wants a hearing to review its rationale. Other companies in the news include Evotec, Eli Lilly, Disarm Therapeutics, AstraZeneca and more.